We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

FURTHER INFORMATION
 
 
 

Related Product News

InfineQ: Cloud-Based Data Processing Software With Near Real-Time Results

Product News

Targeted proteomics start-up ProteiQ Biosciences has announced the launch of InfineQ, its cloud-based solution software for near real-time processing of proteomics data.

READ MORE

DeNovix to Give Away Special Edition Pink CellDrop™ Automated Cell Counter

Product News

DeNovix Inc. will donate a limited edition Pink CellDrop™ Automated Cell Counter to one research lab.

READ MORE

qPCR Master Mix for Reproducible Real-time PCR Experiments

Product News

Thermo Fisher Scientific has launched the Applied Biosystems™ PowerTrack™ SYBR™ Green PCR Master Mix.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE